InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,216.71
(
0.05%
)
US TECH 100
17,660.00
(
0.11%
)
Dow Jones
39,474.54
(
0.22%
)
Brent Oil
82.70
(
-1.49%
)
Bitcoin
60,297.73
(
-4.33%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

LUMA14

Send PM Follow Ignore
Followers 8
Posts 508
Boards Moderated 0
Alias Born 07/04/2014

LUMA14

Re: None

Sunday, 12/18/2016 3:27:47 PM

Sunday, December 18, 2016 3:27:47 PM

Post# of 80490
Ponatinib in Patients With Resistant Chronic Phase Chronic Myeloid Leukemia (CML) to Characterize the Efficacy and Safety of a Range of Doses (OPTIC)

Locations expanded from 92 to 95 world wide

link to study
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up